JP2023536665A5 - - Google Patents
Info
- Publication number
- JP2023536665A5 JP2023536665A5 JP2023507972A JP2023507972A JP2023536665A5 JP 2023536665 A5 JP2023536665 A5 JP 2023536665A5 JP 2023507972 A JP2023507972 A JP 2023507972A JP 2023507972 A JP2023507972 A JP 2023507972A JP 2023536665 A5 JP2023536665 A5 JP 2023536665A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- composition according
- pharmaceutical composition
- antibody
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061749P | 2020-08-05 | 2020-08-05 | |
| US63/061,749 | 2020-08-05 | ||
| PCT/US2021/044449 WO2022031783A2 (en) | 2020-08-05 | 2021-08-04 | Adapter polypeptides and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536665A JP2023536665A (ja) | 2023-08-28 |
| JP2023536665A5 true JP2023536665A5 (https=) | 2024-08-13 |
Family
ID=80117691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507972A Pending JP2023536665A (ja) | 2020-08-05 | 2021-08-04 | アダプターポリペプチドおよびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240299529A1 (https=) |
| EP (1) | EP4192503A2 (https=) |
| JP (1) | JP2023536665A (https=) |
| CN (1) | CN116782932A (https=) |
| CA (1) | CA3190722A1 (https=) |
| WO (1) | WO2022031783A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210093567A1 (en) * | 2019-08-06 | 2021-04-01 | Ohio State Innovation Foundation | Therapeutic extracellular vesicles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2560305C (en) * | 2004-03-19 | 2016-07-05 | Imclone Systems Incorporated | Human anti-epidermal growth factor receptor antibody |
| US20110021974A1 (en) * | 2010-10-05 | 2011-01-27 | Shantha Totada R | Retinitis pigmentosa treatment and prophalaxis |
| JPWO2014003137A1 (ja) * | 2012-06-27 | 2016-06-02 | 旭化成メディカル株式会社 | 高アフィニティー抗体、及びその製造方法 |
| US9566310B2 (en) * | 2012-09-10 | 2017-02-14 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno | Methods of treating muscular dystrophy |
| EP3057662A4 (en) * | 2013-10-17 | 2017-03-29 | Children's Hospital Los Angeles | Antibody dependent exosome therapy |
| EP2985294A1 (en) * | 2014-08-14 | 2016-02-17 | Deutsches Krebsforschungszentrum | Recombinant antibody molecule and its use for target cell restricted T cell activation |
| CN106397592A (zh) * | 2015-07-31 | 2017-02-15 | 苏州康宁杰瑞生物科技有限公司 | 针对程序性死亡配体(pd-l1)的单域抗体及其衍生蛋白 |
| GB2552473A (en) * | 2016-07-21 | 2018-01-31 | Evox Therapeutics Ltd | Surface decoration of extracellular vesicles |
| EP3852770A4 (en) * | 2018-09-21 | 2022-09-14 | City University of Hong Kong | SURFACE MODIFIED EXTRACELLULAR VESICLES |
| CN109082404B (zh) * | 2018-10-22 | 2020-12-25 | 厦门艾赛生物科技有限公司 | 一种靶向性外泌体的制备方法及其应用 |
-
2021
- 2021-08-04 JP JP2023507972A patent/JP2023536665A/ja active Pending
- 2021-08-04 US US18/018,519 patent/US20240299529A1/en active Pending
- 2021-08-04 CN CN202180068299.2A patent/CN116782932A/zh active Pending
- 2021-08-04 EP EP21853397.4A patent/EP4192503A2/en active Pending
- 2021-08-04 WO PCT/US2021/044449 patent/WO2022031783A2/en not_active Ceased
- 2021-08-04 CA CA3190722A patent/CA3190722A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI800506B (zh) | 免疫結合物 | |
| CN110719920B (zh) | 蛋白质异二聚体及其用途 | |
| CN108373504B (zh) | Cd24特异性抗体和抗cd24-car-t细胞 | |
| JP2020096630A5 (https=) | ||
| KR102454460B1 (ko) | 암 치료를 위한 항-fam19a5 항체의 용도 | |
| JP2023545057A (ja) | 抗デクチン－１抗体及びその使用方法 | |
| JP2018537966A (ja) | Ｈｉｖ感染症の予防または処置のための三重特異性および／または三価結合タンパク質 | |
| KR20220044821A (ko) | 세포 표적화를 위한 다중특이적 항원-결합 분자 및 이의 용도 | |
| KR20240168484A (ko) | 인간화 3e10 항체, 변이체, 및 항원 결합 단편 | |
| CN116323667A (zh) | 结合PSMA和γ-δT细胞受体的抗体 | |
| JP2024516713A5 (https=) | ||
| JP2023536665A5 (https=) | ||
| US20250057900A1 (en) | Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein | |
| JP2023545517A5 (https=) | ||
| CN121794286A (zh) | 假型化的病毒颗粒、包含假型化的病毒颗粒的组合物及其用途 | |
| CN119630708A (zh) | 用于治疗癌症的结合分子 | |
| CN119548619A (zh) | 一种双靶点car-t细胞在治疗系统性红斑狼疮及其他b细胞自身免疫病中的用途 | |
| CN120399079B (zh) | 靶向cd90的纳米抗体及其应用 | |
| CN120399078B (zh) | 靶向cd117的纳米抗体及其应用 | |
| TW202411246A (zh) | 經工程化之b型肝炎病毒中和抗體及其用途 | |
| CN119790067A (zh) | 乙肝表面抗原（HBsAg）/CD3双特性抗体及其用途 | |
| CN117858904A (zh) | 特异性结合cd47和pd-l1的分离的双特异性抗体 | |
| KR20260025141A (ko) | 면역 장애를 치료하기 위한 조성물 및 방법 | |
| HK40120997A (zh) | 趋化因子受体8(ccr8)抗体 | |
| EA051933B1 (ru) | Рекомбинантный рабдовирус, который кодирует fc-слитый белок внеклеточного домена cd80 |